Myrobalan Therapeutics logo

Myrobalan Therapeutics Funding & Investors

Myro Therapeutics is a biotechnology company that focuses on the development of therapeutic solutions for Central Nervous System (CNS) disorders. The company's approach is rooted in a deep understanding of disease biology and mechanisms, which allows for the selection of targets that can effectively combat these disorders. Myro Therapeutics has a dedicated team of scientists who work tirelessly to advance the company's research and development efforts. The company has recently celebrated its second anniversary and has also moved into a new office space, indicating a period of growth and expansion.

myrotx.com

Total Amount Raised: $24,400,000

Myrobalan Therapeutics Funding Rounds

  • Grant

    $400,000

    Grant Investors

    ALS Association
  • Series A

    $24,000,000

    Series A Investors

    Cowin Venture
    AB Magnitude Ventures Group
    3E Bioventures Capital
    Guanzi Capital
Funding info provided by Diffbot.